RGC 주가 차트
RGC 재무
Regencell Bioscience Holdings Ltd
$19.69
-3.71%
$-0.75
종가: Jun 11, 16:00:00 GMT-4
$19.58
-0.55%
$-0.11
애프터마켓: Jun 11, 20:00:00 GMT-4
뒤로
Regencell Bioscience Holdings Ltd (RGC) 재무
주요 통계
이전 종가
$20.45
시가
$20.49
일일 범위
$18.94 - $20.85
52주 범위
$9.39 - $83.6
거래량
89.9K
평균 거래량
142.9K
배당수익률
--
EPS(TTM)
-0.01
시가총액
$9.7B
RGC란 무엇인가요?
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 10 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
